CH Biotech R&D (6534.TW) Earnings Analysis
CH Biotech R&D (6534.TW) next reports earnings on 2026-08-06. Trailing P/E 19.37.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6534.TW next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
6534.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | 0.42 TWD | n/a | n/a | n/a |
6534.TW valuation and analyst view
| Trailing P/E | 19.37 |
|---|---|
| Trailing EPS | 4.778 TWD |
| Price / book | 3.56 |
| Dividend yield | 5.18% |
| Market cap | 9.24B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is CH Biotech R&D (6534.TW)'s next earnings date?
CH Biotech R&D is next scheduled to report on 2026-08-06.
Did 6534.TW beat earnings last quarter?
Consensus estimate data was not available for 6534.TW's 2026-03-03 report.
What is 6534.TW's current P/E ratio and EPS?
6534.TW trades at a trailing P/E of 19.37 on trailing EPS of 4.778173294819051 TWD.
What do analysts rate 6534.TW?
6534.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.